Patents by Inventor Edward D. Robinson

Edward D. Robinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7831511
    Abstract: Computer implemented methods, systems, and computer program products for automating the setup of a user's financial management product account for electronic transfer of data between an account at a financial institution and the user's financial management product account, by receiving a link having financial account information, executing the user's financial management product in response to the link, extracting the financial account information from the link, providing the financial account information from the link to the user's financial management product, and configuring the financial management product account to receive electronic transfer of data from the account at the financial institution.
    Type: Grant
    Filed: January 7, 2004
    Date of Patent: November 9, 2010
    Assignee: Intuit Inc.
    Inventors: Muhammet S. Akin, Anne-Marie Colendich, Gary S. Hanson, Anders B. Martinson, Edward D. Robinson, Mark R. Shulman, Jeannie M. Stauffer, Lei Wang
  • Patent number: 7351399
    Abstract: Prodrugs of formula I, their uses, their intermediates, and their method of manufacture are described: and pharmaceutically acceptable prodrugs and salts thereof.
    Type: Grant
    Filed: June 3, 2005
    Date of Patent: April 1, 2008
    Assignee: Metabasis Therapeutics, Inc.
    Inventors: Mark D. Erion, K. Raja Reddy, Edward D. Robinson, Bheemarao G. Ugarkar
  • Patent number: 7285543
    Abstract: Novel purine compounds of Formula 1, pharmaceutically acceptable prodrugs and salts thereof, and their use as fructose 1,6-bisphosphatase inhibitors.
    Type: Grant
    Filed: April 7, 2005
    Date of Patent: October 23, 2007
    Assignee: Metabasis Therapeutics, Inc.
    Inventors: Qun Dang, Mark D. Erion, M. Rami Reddy, Edward D. Robinson, Srinivas Rao Kasibhatla, K. Raja Reddy
  • Patent number: 7157430
    Abstract: This invention is directed to novel (substituted) acyl dipeptidyl ICE/ced-3 family inhibitor compounds. The invention is also directed to pharmaceutical compositions containing these compounds, as well as the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.
    Type: Grant
    Filed: July 20, 2001
    Date of Patent: January 2, 2007
    Assignee: Idun Pharmaceuticals, Inc.
    Inventors: Donald S Karanewsky, Vincent J Kalish, Edward D Robinson, Brett R Ullman
  • Patent number: 6967193
    Abstract: Novel purine compounds of the Formula 1, pharmacuetically acceptable prodrugs and salts thereof, and their use as fructose 1,6-bisphosphatase inhibitors
    Type: Grant
    Filed: July 7, 2003
    Date of Patent: November 22, 2005
    Assignee: Metabasis Therapeutics, Inc.
    Inventors: Qun Dang, Mark D. Erion, M. Rami Reddy, Edward D. Robinson, Srinivas Rao Kasibhatla, K. Raja Reddy
  • Patent number: 6946115
    Abstract: Prodrugs of formula I, their uses, their intermediates, and their method of manufacturing are described: and pharmaceutically acceptable prodrugs and salts thereof.
    Type: Grant
    Filed: October 15, 2001
    Date of Patent: September 20, 2005
    Assignee: Metabasis Therapeutics, Inc.
    Inventors: Mark D. Erion, K. Raja Reddy, Edward D. Robinson, Bheemarao G. Ugarkar
  • Publication number: 20030232788
    Abstract: This invention is directed to novel (substituted)acyl dipeptidyl ICE/ced-3 family inhibitor compounds. The invention is also directed to pharmaceutical compositions containing these compounds, as well as the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.
    Type: Application
    Filed: February 7, 2003
    Publication date: December 18, 2003
    Applicant: Idun Pharmaceuticals, Inc.
    Inventors: Donald S. Karanewsky, Vincent J. Kalish, Edward D. Robinson, Brett R. Ullman
  • Publication number: 20020091089
    Abstract: This invention is directed to novel (substituted)acyl dipeptidyl ICE/ced-3 family inhibitor compounds. The invention is also directed to pharmaceutical compositions containing these compounds, as well as the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.
    Type: Application
    Filed: April 16, 2001
    Publication date: July 11, 2002
    Inventors: Donald S. Karanewsky, Vincent J. Kalish, Edward D. Robinson, Brett R. Ullman
  • Publication number: 20020052345
    Abstract: Prodrugs of formula I, their uses, their intermediates, and their method of manufacture are described: 1
    Type: Application
    Filed: October 15, 2001
    Publication date: May 2, 2002
    Inventors: Mark D. Erion, K. Raja Reddy, Edward D. Robinson, Bheemarao G. Ugarkar
  • Patent number: 6312662
    Abstract: Prodrugs of formula I, their uses, their intermediates, and their method of manufacture are described:
    Type: Grant
    Filed: September 8, 1999
    Date of Patent: November 6, 2001
    Assignee: Metabasis Therapeutics, Inc.
    Inventors: Mark D. Erion, K. Raja Reddy, Edward D. Robinson, Bheemarao G. Ugarkar
  • Patent number: 6284748
    Abstract: Novel purine compounds of the following structure and their use as fructose-1,6-bisphosphatase inhibitors is described.
    Type: Grant
    Filed: March 6, 1998
    Date of Patent: September 4, 2001
    Assignee: Metabasis Therapeutics, Inc.
    Inventors: Qun Dang, Mark D. Erion, M. Rami Reddy, Edward D. Robinson, Srinivas Rao Kasibhatla, K. Raja Reddy
  • Patent number: 6242422
    Abstract: This invention is directed to novel (substituted)acyl dipeptidyl ICE/ced-3 family inhibitor compounds. The invention is also directed to pharmaceutical compositions containing these compounds, as well as the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.
    Type: Grant
    Filed: October 22, 1998
    Date of Patent: June 5, 2001
    Assignee: Idun Pharmacueticals, Inc.
    Inventors: Donald S. Karanewsky, Vincent J. Kalish, Edward D. Robinson, Brett R. Ullman